A typical cell is surrounded by a membrane that functions as a barrier that restricts the exchange of molecules
between the inside and the outside of that cell. Consequently, this traffic control limits our ability to study and manipulate
intracellular processes by exogenous reagents. We now understand that many human diseases, such as cancer, result from abnormal
cellular processes, highlighting the importance of development of technologies which can extend our control over living cells
both in vitro and in vivo for drug discovery and development.
The Celtek team has significant experience and expertise
in the field of cellular delivery technology, and is actively using and continuously developing various novel, non-destructive
cellular delivery technologies, by which peptides, proteins, and oligonucleotides can be imported into a wide range of cell
types, including tumor cells. These compounds are designed to address disease at the cellular level, which is especially effective
in cancer therapy. Cellular delivery technologies have broad application in basic biomedical research, preclinical drug research,
and therapeutic use.
Celtek’s patent-protected cellular delivery technologies have been demonstrated superior
efficacy, as compared to known cell-permeable agents. Our novel technologies have been incorporated into our preclinical drug
products to vastly enhance their therapeutic efficacy. If you are interested in learning more about these new technologies
and/or would like to consider licensing opportunities, please contact us.